Glycorex Transplantation AB (GTAB B) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Boule Diagnostics AB

Redsense Medical AB

Q-linea AB

Glycorex Transplantation AB

Episurf Medical AB

Clinical Laserthermia Systems AB

Dignitana AB

Corline Biomedical AB

SciBase Holding AB

Lumito AB

Irras AB

Why is Glycorex Transplantation AB ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Glycorex Transplantation AB for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Glycorex Transplantation AB

-100.0%

1.19

113.85%

OMX Stockholm 30

17.06%

0.24

18.06%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.56%

EBIT Growth (5y)

-5.13%

EBIT to Interest (avg)

-14.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.27

Sales to Capital Employed (avg)

0.75

Tax Ratio

0.67%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.87

EV to EBIT

-19.27

EV to EBITDA

74.01

EV to Capital Employed

4.74

EV to Sales

3.79

PEG Ratio

Dividend Yield

ROCE (Latest)

-24.61%

ROE (Latest)

-20.29%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 1.6 MM

RAW MATERIAL COST(Y)

Fallen by -62.43% (YoY

OPERATING PROFIT(Q)

Highest at SEK 0.93 MM

OPERATING PROFIT MARGIN(Q)

Highest at 9.59 %

PRE-TAX PROFIT(Q)

Highest at SEK -1.66 MM

NET PROFIT(Q)

Highest at SEK -1.66 MM

EPS(Q)

Highest at SEK -0.02

-5What is not working for the Company

INTEREST(9M)

At SEK 0.38 MM has Grown at 109.44%

CASH AND EQV(HY)

Lowest at SEK 21.23 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 8.13%

Here's what is working for Glycorex Transplantation AB

Operating Cash Flow

Highest at SEK 1.6 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Operating Profit

Highest at SEK 0.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin

Highest at 9.59 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at SEK -1.66 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Pre-Tax Profit

At SEK -1.66 MM has Grown at 39.83%

over average net sales of the previous four periods of SEK -2.75 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

Highest at SEK -1.66 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS

Highest at SEK -0.02

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost

Fallen by -62.43% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at SEK 2.36 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Glycorex Transplantation AB

Interest

At SEK 0.38 MM has Grown at 109.44%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Cash and Eqv

Lowest at SEK 21.23 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 8.13%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio